BAKER BROS. ADVISORS LP 13D/13G Filings for Heron Therapeutics, Inc. (HRTX)

BAKER BROS. ADVISORS LP 13D and 13G filings for Heron Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-02-14
4:21 pm
Sale		2023-12-3113GHeron Therapeutics, Inc.
HRTX		BAKER BROS. ADVISORS LP7,881,933
4.990%		-249,745decrease
(-3.07%)		Filing
2022-02-14
4:15 pm
Purchase		2021-12-3113GHeron Therapeutics, Inc.
HRTX		BAKER BROS. ADVISORS LP8,131,678
8.000%		66,846increase
(+0.83%)		Filing
2021-02-16
5:09 pm
Purchase		2020-12-3113GHeron Therapeutics, Inc.
HRTX		BAKER BROS. ADVISORS LP8,064,832
8.700%		84,979increase
(+1.06%)		Filing
2020-02-14
4:14 pm
Purchase		2019-12-3113GHeron Therapeutics, Inc.
HRTX		BAKER BROS. ADVISORS LP7,979,853
8.700%		1,071,609increase
(+15.51%)		Filing